Therapeutic Antibodies: Status, Strategies and Outlook

Therapeutic antibodies are central to pharmaceutical development; needless to say, emphasis is continually on developing new methods and improving those already in place. Play an active role in the war against disease – register online today!
Jan. 13, 2011 - PRLog -- This intensive class begins with a comprehensive overview of antibodies and builds a steady platform of knowledge about the potential development strategies. Having analysed and understood the historical, scientific, technological and legal context surrounding today’s market, delegates can then expect detailed and specific advice on improving generated antibodies from a scientific and business perspective. In this, the longest session in the masterclass, invaluable, tangible expertise and advice will highlight some of the possible ways to get the most out of your antibody projects.

By attending this Masterclass, you will be able to:

Understand the contextual backdrop to the therapeutic antibody industry

Discuss the latest generation of  antibodies and their features

Learn from the advice offered and apply to your own projects

For further information and the opportunity to register online please visit

# # #

SMi have had an established portfolio of Pharmaceutical, Defence, Energy, Finance and PPP/PFI events running since 1993. We are at the forefront of linking businesses with information, organising over 150 Conferences, Workshops and Masterclasses every year. All our events are research driven and highly targeted towards senior level professionals, designed to help you make informed decisions and remain at the cutting edge of business information.
Source:SMi Group
Posted By:*** Email Verified
Phone:+44 (0)20 7827 6000
Zip:SE1 0HS
Tags:Therapeutics, Antibodies, Immunology, Disease, Pharmaceutical, Medical, Drug Development
Location:London City - London, Greater - England
Account Email Address Verified     Disclaimer     Report Abuse

Like PRLog?
Click to Share